亞諾法

-0.05 (-0.25%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

20.2545成交張數27.36本益比0.96股價淨值比0.54%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	14	13	5.9%	14.57	21.03	3.6%	3.3%	0.1	0.1
2026Q1	13	13	6.1%	14.10	20.92	0.1%	0.1%	0.2	0.2
2025Q4	13	13	5.3%	17.02	20.75	-0.1%	-0.1%	0.1	0.1
2025Q3	13	12	5.6%	15.77	20.52	0.1%	0.1%	0.0	0.0
2025Q2	14	12	10.6%	7.83	20.33	-0.5%	-0.5%	-0.1	-0.1
2025Q1	14	13	10.0%	8.51	20.95	3.8%	3.5%	-0.1	-0.1
2024Q4	14	13	6.5%	14.95	21.62	4.8%	4.5%	0.1	0.0
2024Q3	14	13	5.6%	13.40	21.39	4.6%	4.3%	-0.1	-0.1
2024Q2	14	13	6.0%	12.50	21.34	5.1%	4.7%	0.4	0.4
2024Q1	14	13	7.9%	9.31	21.02	4.7%	4.3%	0.1	0.1
2023Q4	14	13	5.1%	14.69	21.24	3.4%	3.2%	-0.0	-0.1
2023Q3	14	13	6.3%	12.03	21.15	3.5%	3.3%	0.0	0.0
2023Q2	14	13	10.2%	7.20	20.93	5.0%	4.5%	0.5	0.4
2023Q1	14	13	9.0%	8.16	20.70	5.6%	5.1%	0.3	0.2
2022Q4	14	13	6.0%	12.75	21.34	6.0%	5.6%	0.2	0.2
2022Q3	13	12	6.9%	10.05	20.50	5.1%	4.7%	0.5	0.5
2022Q2	13	12	6.1%	11.47	20.03	4.0%	3.7%	0.3	0.3
2022Q1	13	12	7.3%	9.03	19.88	3.0%	2.8%	0.3	0.3
2021Q4	13	12	5.6%	12.54	20.01	2.3%	2.2%	0.2	0.2
2021Q3	13	12	5.4%	12.33	19.78	3.3%	3.1%	0.3	0.3
2021Q2	13	12	9.4%	6.95	19.58	3.5%	3.2%	0.3	0.3
2021Q1	13	12	8.4%	7.77	19.50	3.3%	3.0%	0.1	0.1
2020Q4	13	12	6.5%	10.38	20.00	3.0%	2.9%	0.3	0.3
2020Q3	13	12	6.4%	9.78	19.92	2.4%	2.3%	0.4	0.4
2020Q2	13	12	5.5%	11.01	19.74	1.2%	1.1%	0.3	0.2
2020Q1	13	12	6.0%	10.15	19.70	1.1%	1.0%	0.0	0.0
2019Q4	13	12	5.7%	10.94	19.69	0.3%	0.3%	0.2	0.2
2019Q3	13	12	6.0%	10.28	19.70	1.4%	1.3%	0.3	0.3
2019Q2	13	12	7.9%	7.87	19.84	2.1%	2.0%	0.2	0.2
2019Q1	13	12	5.1%	13.24	20.30	2.9%	2.8%	0.1	0.0
2018Q4	13	12	5.2%	11.03	20.27	3.8%	3.5%	0.6	0.5
2018Q3	13	12	5.3%	11.80	19.66	3.7%	3.4%	0.2	0.2
2018Q2	13	12	8.5%	7.49	19.55	4.3%	4.0%	0.0	-0.0
2018Q1	13	12	5.5%	11.45	20.14	4.6%	4.3%	0.1	-0.1
2017Q4	13	12	6.1%	11.18	20.23	4.9%	4.6%	0.2	0.0
2017Q3	13	12	8.1%	8.54	20.08	5.3%	4.9%	0.1	0.1
2017Q2	13	12	7.9%	8.65	20.21	4.7%	4.3%	0.2	-0.2
2017Q1	13	12	6.5%	10.92	20.16	4.3%	4.0%	0.1	-0.0
2016Q4	12	12	5.8%	12.48	20.01	–	–	0.1	-0.2
2016Q3	12	12	6.3%	11.79	19.76	–	–	0.3	0.1